Back
Incyte Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
49
INCY
Incyte
Last Price:
65.71
Seasonality Move:
10.85%
Sell
40
ALNY
Alnylam Pharmaceuticals
Last Price:
273.83
Seasonality Move:
3.21%
Sell
49
Incyte (INCY)
is a Sell
Is Incyte a Buy, Sell or Hold?
- The current Incyte [INCY] share price is $65.73. The Score for INCY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- INCY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $273.88. The Score for ALNY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INCY Stock Price Chart
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $273.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
INCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.58 | Buy |
| Relative Strength Index (14 RSI): | 55.6 | Buy |
| Chaikin Money Flow: | 709758 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.88 - 65.92) | Buy |
| Bollinger Bands (100): | (57.37 - 65.31) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.42 | Buy |
| Relative Strength Index (14 RSI): | 58.09 | Buy |
| Chaikin Money Flow: | 377648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (257.34 - 278.94) | Buy |
| Bollinger Bands (100): | (166.06 - 270.8) | Buy |
INCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.08 | Buy |
| 20-day SMA: | 64.65 | Buy |
| 50-day SMA: | 64.33 | Buy |
| 200-day SMA: | 60.05 | Buy |
| 8-day EMA: | 65.31 | Buy |
| 20-day EMA: | 64.6 | Buy |
| 50-day EMA: | 63.61 | Buy |
| 200-day EMA: | 61.31 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 269.63 | Buy |
| 20-day SMA: | 266.18 | Buy |
| 50-day SMA: | 260.04 | Buy |
| 200-day SMA: | 192.17 | Buy |
| 8-day EMA: | 270.19 | Buy |
| 20-day EMA: | 266.62 | Buy |
| 50-day EMA: | 254.32 | Buy |
| 200-day EMA: | 208.68 | Buy |
Incyte Earnings Growth & INCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, an increase next quarter of $0.16 per share, a decrease this year of $2.06 per share, and an increase next year of $4.38 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Incyte Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||